Transformation of rodent fibroblasts by ICP4, the major transactivating protein of herpes simplex virus type

International Journal of Oncology

Volumn 10, Issue 4, 1997, Pages 765-773

  Descalzo, Adriana M ^a,b   Weiand, Claudia ^a   Dietze, Lutz ^a   Matz, Bertfried ^a,c   Bauer, Georg ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^c UNIVERSITY OF BONN   (Germany)

Author keywords

Fibroblast; HSV; ICP4; Transformation

Indexed keywords

VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; FIBROBLAST; HERPES SIMPLEX VIRUS 1; NONHUMAN; PRIORITY JOURNAL; RAT; VIRUS CELL TRANSFORMATION;

EID: 0030972655     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Duff R and Rapp F: Oncogenic transformation of hamster cells after exposure to herpes simplex virus type 2. Nature New Biol 233: 45-50, 1971.
2. Duff R and Rapp F: Oncogenic transformation of hamster embryo cells after exposure to inactivated herpes simplex virus type 1. J Virol 12: 209-217, 1973.
3. MacNab JCM: Transformation of rat embryo cells by temperature sensitive mutants of herpes simplex virus. J Gen Viral 24: 143-153, 1974.
4. Schröder CH, Kaerner HC, Munk K and Darai G: Morphological transformation of rat embryonic fibroblasts by abortive herpes simplex virus infection: increased transformation rate correlated to a defective viral genotype. Intervirology 8: 164-171, 1977.
5. Skinner GBR: Transformation of primary hamster embryo fibroblasts by type 2 herpes simplex virus: evidence for a hit-and-run mechanism. Brit J Exp Path 57: 361-376, 1976.
6. Takahashi M and Yamanishi K: Transformation of hamster embryo and human embryo cells by temperature sensitive mutants of herpes simplex virus type 2. Virology 61: 306-311, 1974.
7. Bauer G, Kahl S, Singh Sawhney I, Höfler P, Gerspach R and Matz B: Transformation of rodent fibroblasts by herpes simplex virus: presence of morphological transforming region 1 (mtr 1) is not required for the maintenance of the transformed state. Int J Cancer 51: 754-760, 1992.
8. Galloway DA and McDougall JK: The oncogenic potential of herpes simplex viruses: evidence for a 'hit-and-run' mechanism. Nature 302: 21-24, 1983.
9. Schlehofer JR and zur Hausen H: Induction of mutations within the host cell genome by partially inactivated herpes virus type 1. Virology 122: 471-475, 1982.
10. Clarke P and Clements JB: Mutagenesis occurring following infection with herpes simplex virus does not require virus replication. Virology 182: 597-606, 1991.
11. Johnson PA, Miyanohara A, Levine F, Cahill T and Friedmann T: Cytotoxicity of a replication-defective mutant of herpes simplex virus type 1. J Virol 66: 2952-2965, 1992.
12. Johnson PA, Wang MJ and Friedmann T: Improved cell survival by the reduction of immediate-early gene expression in replication-defective mutants of herpes simplex virus type 1 but not by mutation of the virion host shutoff function. J Virol 68: 6347-6362, 1994.
13. EJ pSV2neo or pSV2neo genes into rat mammary cells: rapid stimulation of clonal diversification of spontaneous metastatic and cell-surface properties. Oncogene 7: 1127-1135, 1992.
14. Dichgans C, Höfler P and Bauer G: Transformation of rat fibroblasts by TGF-β: restriction to a minor subpopulation, rather than a rare event. Int J Oncol 7: 1367-1371, 1995.
15. Melchinger W, Strauss S, Zucker B and Bauer G: Antiapoptotic activity of bovine papilloma virus: implications for the control of oncogenesis. Int J Oncol 9: 927-933, 1996.
16. Jürgensmeier JM and Bauer G: Interference of Bcl-2 with intercellular control of oncogenesis. Int J Cancer (In press).